Let's Be More Sensitive-How SGLT-2 Inhibitors and GLP-1 Receptor Agonists Affect beta-Cell Function in Type 2 Diabetes. Pratley R. J Clin Endocrinol Metab 2020;105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pratley R. Let's Be More Sensitive-How SGLT-2 Inhibitors and GLP-1 Receptor Agonists Affect beta-Cell Function in Type 2 Diabetes. J Clin Endocrinol Metab 2020;105.
PMID: 33074334